A black box warning is the strongest safety alert the U.S. Food and Drug Administration (FDA) can place on a prescription drug. It signals that the medication carries a risk of serious or life-threatening side effects, and it appears as bold text inside a bordered box on the drug’s official prescribing information. The name comes from that distinctive black border. Hundreds of commonly prescribed medications carry one, and understanding what it means can help you make more informed decisions about your treatment.
Why the FDA Issues a Boxed Warning
The FDA adds a boxed warning when there is reasonable evidence that a drug is associated with a serious hazard, particularly one that could lead to death or severe injury. Importantly, a proven cause-and-effect relationship is not required. If the evidence consistently points to a dangerous pattern, that is enough. In rare cases, serious toxicity observed in animal studies can trigger a boxed warning even without matching data in humans.
When a safety concern surfaces from clinical trials or from reports submitted to the FDA’s adverse event reporting system, an interdisciplinary team at the agency reviews the evidence. That team then decides whether to continue monitoring, require a boxed warning, or pull the drug from the market entirely. Less serious concerns get added to a lower-level “Warnings and Precautions” section of the label instead.
Where It Fits in the FDA’s Safety Hierarchy
Drug labels contain several layers of safety information, and the boxed warning sits at the very top. Below it, the “Contraindications” section lists situations where a drug should not be used at all (for example, a known severe allergy). The “Warnings and Precautions” section covers risks that are real but less severe or less likely. Think of the boxed warning as the FDA’s way of saying: this risk is serious enough that every prescriber and patient needs to see it before anything else.
A boxed warning does not mean a drug is banned or that you should never take it. Physicians can still prescribe medications that carry one. They are expected to share the relevant risks with you, but they use professional judgment to weigh those risks against the benefits for your specific situation.
What a Boxed Warning Looks Like
On the official prescribing information (the detailed document that comes with every prescription drug), the boxed warning appears at the very beginning, before all other sections. The FDA requires the text to be formatted in bold print and presented with bullet points or subheadings so it is easy to scan. The black border surrounding the text is what gives it its informal name.
For certain drugs with boxed warnings, the FDA also requires a Medication Guide: a plain-language handout written specifically for patients. Your pharmacy is required to give you this guide in paper form each time you fill the prescription, though you can request an electronic copy instead. Not every drug with a boxed warning triggers a Medication Guide requirement, but many do, especially when the FDA determines that knowing about the risk could change whether you’d choose to take the medication.
Common Medications That Carry One
Some of the most widely prescribed drug classes in the country have boxed warnings. A few well-known examples:
- Antidepressants (SSRIs and similar drugs): Carry a warning about increased risk of worsening depression, agitation, and suicidal thinking in children, adolescents, and young adults up to age 24, especially early in treatment.
- Fluoroquinolone antibiotics: Warn of increased risk of tendinitis and tendon rupture, particularly in older adults, organ transplant recipients, and people taking steroids.
- Isotretinoin (originally sold as Accutane): Warns of severe birth defects if taken during pregnancy, along with potential depression, psychosis, and suicidal thoughts.
- ACE inhibitors (common blood pressure drugs): Can cause serious harm or death to an unborn baby during pregnancy.
- Atypical antipsychotics: Increase the risk of death in elderly patients with dementia-related psychosis.
If you’ve taken any of these, the boxed warning doesn’t mean the drug was wrong for you. It means your prescriber weighed the risk against your need and decided the benefit was greater.
How Boxed Warnings Change Prescribing
These warnings have a measurable effect on how doctors prescribe. One of the most studied examples is the 2004 boxed warning added to antidepressants regarding suicide risk in young people. Within a month, the number of antidepressant prescriptions filled for children dropped 10% nationally. By mid-2005, prescriptions for children and adolescents had fallen another 10%.
A survey of 247 physicians who prescribed antidepressants found that 94% were aware of the warning. About 76% reported prescribing at the same rate, while 24% had decreased or stopped prescribing antidepressants. The effect was sharpest among general practitioners treating only children and adolescents: 82% of that group reduced or stopped prescribing, compared to 28% of generalists treating only adults.
Beyond prescription volume, boxed warnings shift how doctors manage care. After the antidepressant warning, 35% of psychiatrists reported spending more time reviewing treatment plans at initial visits. Roughly 43% of specialists and 26% of generalists increased their referrals to psychiatrists or other mental health professionals. Some physicians began trying counseling before medication. In other words, the warning didn’t just reduce prescriptions. It changed the entire approach to treatment for many providers.
Legal Significance
Boxed warnings carry weight in the courtroom. Some courts have treated a boxed warning as adequate notice to prescribers about a drug’s risks, which can shield the manufacturer from product liability claims. The reasoning is that once the manufacturer clearly warned about the danger, responsibility shifts to the prescribing physician to weigh that risk for each patient. This legal dynamic is one reason pharmaceutical companies sometimes prefer a clear boxed warning over vague, buried language: it provides a documented record that the risk was communicated.
Can a Boxed Warning Be Removed?
Yes. If new evidence shows that a risk was overstated or that benefits clearly outweigh it for a particular population, the FDA can remove or downgrade a boxed warning. A recent example involves hormone replacement therapy (HRT) for menopause. HRT products had carried a boxed warning for years, but the FDA initiated removal after reassessing the literature, including data from women who started HRT within ten years of menopause onset. An analysis of 30 trials involving over 26,000 women found HRT was not associated with increased cancer mortality, and women who began treatment before age 60 appeared to have a decreased mortality risk overall. The FDA requested updated labeling to reflect a more balanced picture of benefits and risks.
Removal is not common, and it requires substantial evidence that the original concern no longer holds up. But the process shows that boxed warnings are not permanent marks. They evolve as the science does.